Risk factors of multiple system atrophy: A case‐control study in French patients
Identifieur interne : 002640 ( Main/Curation ); précédent : 002639; suivant : 002641Risk factors of multiple system atrophy: A case‐control study in French patients
Auteurs : Jean-Sébastien Vidal [France] ; Marie Vidailhet [France] ; Alexis Elbaz [France] ; Pascal Derkinderen [France] ; Christophe Tzourio [France] ; Annick Alpérovitch [France]Source :
- Movement Disorders [ 0885-3185 ] ; 2008-04-30.
Descripteurs français
- Pascal (Inist)
- Wicri :
- geographic : France.
- topic : Habitude alimentaire, Homme.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Alcohol Drinking (epidemiology), Case control study, Case-Control Studies, Disease Progression, Environmental Exposure, Epidemiology, Female, Food Habits, Food habit, France (epidemiology), French, Human, Humans, Interviews as Topic, Life Style, Male, Middle Aged, Multiple System Atrophy (epidemiology), Multiple System Atrophy (etiology), Multiple System Atrophy (prevention & control), Multiple system atrophy, Nervous system diseases, Patient Selection, Questionnaires, Reference Values, Risk Factors, Risk factor, anti‐inflammatory agents, nonsteroidal, environmental exposure, epidemiology, food habits, multiple system atrophy, occupation.
- MESH :
- geographic , epidemiology : France.
- epidemiology : Alcohol Drinking, Multiple System Atrophy.
- etiology : Multiple System Atrophy.
- prevention & control : Multiple System Atrophy.
- Adult, Aged, Aged, 80 and over, Case-Control Studies, Disease Progression, Environmental Exposure, Female, Food Habits, Humans, Interviews as Topic, Life Style, Male, Middle Aged, Patient Selection, Questionnaires, Reference Values, Risk Factors.
Abstract
Multiple system atrophy (MSA) is a rare sporadic progressive neurodegenerative disorder. MSA risk factors are poorly known. The objectives of this case‐control study were to study environmental risk factors associated with MSA. Cases were recruited through five French referral centers. Controls matched for age, gender, and living area were recruited from healthy relatives of inpatients free of any parkinsonian syndrome of the same centers. Subjects were interviewed about exposure to environmental factors (pesticides, solvents, etc.), occupation and food habits, and use of anti‐inflammatory drugs. Odds ratios and 95% confident intervals (OR [95% CI]) were computed using conditional logistic regression. Seventy‐one cases and 71 matched controls were included. Low education level was more frequent in cases than in controls. Controls drank more alcohol than did cases (OR = 0.5 [0.2–1.1]) and the risk of MSA decreased with increasing alcohol consumption (P = 0.04). Controls ate fish and sea food more often and drank more tea than cases. Aspirin intake was more frequent among controls than did cases (OR = 0.5 [0.2–1.0]) and the risk of MSA decreased with the frequency of intake (P = 0.0002). MSA was not associated to exposure to pesticides, solvents, and other toxics neither to occupations, except plant and machine operators and assemblers (OR = 10.0 [2.1–47.5]) where the risk of MSA increased with number of years in this occupation (P = 0.004). This case‐control study provided new findings about risk factors of MSA. On another hand, it did not confirm the previously reported association between MSA and exposure to pesticides. © 2008 Movement Disorder Society
Url:
DOI: 10.1002/mds.21857
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000649
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :000649
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001196
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002312
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :002312
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002095
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :002049
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :002049
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002049
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :003218
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001269
- to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :001A50
- to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001102
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :003710
Links to Exploration step
ISTEX:1B70D7EE8D46D33E3294BD13CA164FE92A56515FLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Risk factors of multiple system atrophy: A case‐control study in French patients</title>
<author><name sortKey="Vidal, Jean Ebastien" sort="Vidal, Jean Ebastien" uniqKey="Vidal J" first="Jean-Sébastien" last="Vidal">Jean-Sébastien Vidal</name>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
</author>
<author><name sortKey="Elbaz, Alexis" sort="Elbaz, Alexis" uniqKey="Elbaz A" first="Alexis" last="Elbaz">Alexis Elbaz</name>
</author>
<author><name sortKey="Derkinderen, Pascal" sort="Derkinderen, Pascal" uniqKey="Derkinderen P" first="Pascal" last="Derkinderen">Pascal Derkinderen</name>
</author>
<author><name sortKey="Tzourio, Christophe" sort="Tzourio, Christophe" uniqKey="Tzourio C" first="Christophe" last="Tzourio">Christophe Tzourio</name>
</author>
<author><name sortKey="Alperovitch, Annick" sort="Alperovitch, Annick" uniqKey="Alperovitch A" first="Annick" last="Alpérovitch">Annick Alpérovitch</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:1B70D7EE8D46D33E3294BD13CA164FE92A56515F</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.21857</idno>
<idno type="url">https://api.istex.fr/document/1B70D7EE8D46D33E3294BD13CA164FE92A56515F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000649</idno>
<idno type="wicri:Area/Istex/Curation">000649</idno>
<idno type="wicri:Area/Istex/Checkpoint">001196</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Vidal J:risk:factors:of</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:18307243</idno>
<idno type="wicri:Area/PubMed/Corpus">002312</idno>
<idno type="wicri:Area/PubMed/Curation">002312</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002095</idno>
<idno type="wicri:Area/Ncbi/Merge">002049</idno>
<idno type="wicri:Area/Ncbi/Curation">002049</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002049</idno>
<idno type="wicri:Area/Main/Merge">003218</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:08-0251859</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001269</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001A50</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001102</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Vidal J:risk:factors:of</idno>
<idno type="wicri:Area/Main/Merge">003710</idno>
<idno type="wicri:Area/Main/Curation">002640</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Risk factors of multiple system atrophy: A case‐control study in French patients</title>
<author><name sortKey="Vidal, Jean Ebastien" sort="Vidal, Jean Ebastien" uniqKey="Vidal J" first="Jean-Sébastien" last="Vidal">Jean-Sébastien Vidal</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U708, Neuroepidemiology, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>U708, Université Paris 6, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Department of Neurology, Hôpital Saint‐Antoine, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Department of Neurology, Hôpital Saint‐Antoine, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U679, Neurology and Experimental Therapeutics, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Elbaz, Alexis" sort="Elbaz, Alexis" uniqKey="Elbaz A" first="Alexis" last="Elbaz">Alexis Elbaz</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U708, Neuroepidemiology, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>U708, Université Paris 6, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Derkinderen, Pascal" sort="Derkinderen, Pascal" uniqKey="Derkinderen P" first="Pascal" last="Derkinderen">Pascal Derkinderen</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Department of Neurology, Center of Clinical Investigations, Hôpital Laënnec, Nantes</wicri:regionArea>
<placeName><settlement type="city">Nantes</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tzourio, Christophe" sort="Tzourio, Christophe" uniqKey="Tzourio C" first="Christophe" last="Tzourio">Christophe Tzourio</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U708, Neuroepidemiology, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>U708, Université Paris 6, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Alperovitch, Annick" sort="Alperovitch, Annick" uniqKey="Alperovitch A" first="Annick" last="Alpérovitch">Annick Alpérovitch</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U708, Neuroepidemiology, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>U708, Université Paris 6, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-04-30">2008-04-30</date>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="797">797</biblScope>
<biblScope unit="page" to="803">803</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">1B70D7EE8D46D33E3294BD13CA164FE92A56515F</idno>
<idno type="DOI">10.1002/mds.21857</idno>
<idno type="ArticleID">MDS21857</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Alcohol Drinking (epidemiology)</term>
<term>Case control study</term>
<term>Case-Control Studies</term>
<term>Disease Progression</term>
<term>Environmental Exposure</term>
<term>Epidemiology</term>
<term>Female</term>
<term>Food Habits</term>
<term>Food habit</term>
<term>France (epidemiology)</term>
<term>French</term>
<term>Human</term>
<term>Humans</term>
<term>Interviews as Topic</term>
<term>Life Style</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Multiple System Atrophy (epidemiology)</term>
<term>Multiple System Atrophy (etiology)</term>
<term>Multiple System Atrophy (prevention & control)</term>
<term>Multiple system atrophy</term>
<term>Nervous system diseases</term>
<term>Patient Selection</term>
<term>Questionnaires</term>
<term>Reference Values</term>
<term>Risk Factors</term>
<term>Risk factor</term>
<term>anti‐inflammatory agents, nonsteroidal</term>
<term>environmental exposure</term>
<term>epidemiology</term>
<term>food habits</term>
<term>multiple system atrophy</term>
<term>occupation</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>France</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Alcohol Drinking</term>
<term>Multiple System Atrophy</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Multiple System Atrophy</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Multiple System Atrophy</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Case-Control Studies</term>
<term>Disease Progression</term>
<term>Environmental Exposure</term>
<term>Female</term>
<term>Food Habits</term>
<term>Humans</term>
<term>Interviews as Topic</term>
<term>Life Style</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Patient Selection</term>
<term>Questionnaires</term>
<term>Reference Values</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Atrophie multisystématisée</term>
<term>Epidémiologie</term>
<term>Etude cas témoin</term>
<term>Facteur risque</term>
<term>Français</term>
<term>Habitude alimentaire</term>
<term>Homme</term>
<term>Pathologie du système nerveux</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Habitude alimentaire</term>
<term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Multiple system atrophy (MSA) is a rare sporadic progressive neurodegenerative disorder. MSA risk factors are poorly known. The objectives of this case‐control study were to study environmental risk factors associated with MSA. Cases were recruited through five French referral centers. Controls matched for age, gender, and living area were recruited from healthy relatives of inpatients free of any parkinsonian syndrome of the same centers. Subjects were interviewed about exposure to environmental factors (pesticides, solvents, etc.), occupation and food habits, and use of anti‐inflammatory drugs. Odds ratios and 95% confident intervals (OR [95% CI]) were computed using conditional logistic regression. Seventy‐one cases and 71 matched controls were included. Low education level was more frequent in cases than in controls. Controls drank more alcohol than did cases (OR = 0.5 [0.2–1.1]) and the risk of MSA decreased with increasing alcohol consumption (P = 0.04). Controls ate fish and sea food more often and drank more tea than cases. Aspirin intake was more frequent among controls than did cases (OR = 0.5 [0.2–1.0]) and the risk of MSA decreased with the frequency of intake (P = 0.0002). MSA was not associated to exposure to pesticides, solvents, and other toxics neither to occupations, except plant and machine operators and assemblers (OR = 10.0 [2.1–47.5]) where the risk of MSA increased with number of years in this occupation (P = 0.004). This case‐control study provided new findings about risk factors of MSA. On another hand, it did not confirm the previously reported association between MSA and exposure to pesticides. © 2008 Movement Disorder Society</div>
</front>
</TEI>
<double idat="0885-3185:2008:Vidal J:risk:factors:of"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Risk Factors of Multiple System Atrophy : A Case-Control Study in French Patients</title>
<author><name sortKey="Vidal, Jean Sebastien" sort="Vidal, Jean Sebastien" uniqKey="Vidal J" first="Jean-Sébastien" last="Vidal">Jean-Sébastien Vidal</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>INSERM U708, Neuroepidemiology</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>U708, Université Paris 6</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology, Hôpital Saint-Antoine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology, Hôpital Saint-Antoine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>INSERM U679, Neurology and Experimental Therapeutics</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Elbaz, Alexis" sort="Elbaz, Alexis" uniqKey="Elbaz A" first="Alexis" last="Elbaz">Alexis Elbaz</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>INSERM U708, Neuroepidemiology</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>U708, Université Paris 6</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Derkinderen, Pascal" sort="Derkinderen, Pascal" uniqKey="Derkinderen P" first="Pascal" last="Derkinderen">Pascal Derkinderen</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Department of Neurology, Center of Clinical Investigations, Hôpital Laënnec</s1>
<s2>Nantes</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Nantes</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tzourio, Christophe" sort="Tzourio, Christophe" uniqKey="Tzourio C" first="Christophe" last="Tzourio">Christophe Tzourio</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>INSERM U708, Neuroepidemiology</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>U708, Université Paris 6</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Alperovitch, Annick" sort="Alperovitch, Annick" uniqKey="Alperovitch A" first="Annick" last="Alperovitch">Annick Alperovitch</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>INSERM U708, Neuroepidemiology</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>U708, Université Paris 6</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0251859</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0251859 INIST</idno>
<idno type="RBID">Pascal:08-0251859</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001269</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001A50</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001102</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Vidal J:risk:factors:of</idno>
<idno type="wicri:Area/Main/Merge">003710</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Risk Factors of Multiple System Atrophy : A Case-Control Study in French Patients</title>
<author><name sortKey="Vidal, Jean Sebastien" sort="Vidal, Jean Sebastien" uniqKey="Vidal J" first="Jean-Sébastien" last="Vidal">Jean-Sébastien Vidal</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>INSERM U708, Neuroepidemiology</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>U708, Université Paris 6</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology, Hôpital Saint-Antoine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology, Hôpital Saint-Antoine</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>INSERM U679, Neurology and Experimental Therapeutics</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Elbaz, Alexis" sort="Elbaz, Alexis" uniqKey="Elbaz A" first="Alexis" last="Elbaz">Alexis Elbaz</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>INSERM U708, Neuroepidemiology</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>U708, Université Paris 6</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Derkinderen, Pascal" sort="Derkinderen, Pascal" uniqKey="Derkinderen P" first="Pascal" last="Derkinderen">Pascal Derkinderen</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Department of Neurology, Center of Clinical Investigations, Hôpital Laënnec</s1>
<s2>Nantes</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Nantes</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tzourio, Christophe" sort="Tzourio, Christophe" uniqKey="Tzourio C" first="Christophe" last="Tzourio">Christophe Tzourio</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>INSERM U708, Neuroepidemiology</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>U708, Université Paris 6</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Alperovitch, Annick" sort="Alperovitch, Annick" uniqKey="Alperovitch A" first="Annick" last="Alperovitch">Annick Alperovitch</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>INSERM U708, Neuroepidemiology</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>U708, Université Paris 6</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Case control study</term>
<term>Epidemiology</term>
<term>Food habit</term>
<term>French</term>
<term>Human</term>
<term>Multiple system atrophy</term>
<term>Nervous system diseases</term>
<term>Risk factor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Atrophie multisystématisée</term>
<term>Pathologie du système nerveux</term>
<term>Facteur risque</term>
<term>Etude cas témoin</term>
<term>Français</term>
<term>Homme</term>
<term>Epidémiologie</term>
<term>Habitude alimentaire</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Habitude alimentaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Multiple system atrophy (MSA) is a rare sporadic progressive neurodegenerative disorder. MSA risk factors are poorly known. The objectives of this case-control study were to study environmental risk factors associated with MSA. Cases were recruited through five French referral centers. Controls matched for age, gender, and living area were recruited from healthy relatives of inpatients free of any parkinsonian syndrome of the same centers. Subjects were interviewed about exposure to environmental factors (pesticides, solvents, etc.), occupation and food habits, and use of anti-inflammatory drugs. Odds ratios and 95% confident intervals (OR [95% CI]) were computed using conditional logistic regression. Seventy-one cases and 71 matched controls were included. Low education level was more frequent in cases than in controls. Controls drank more alcohol than did cases (OR = 0.5 [0.2-1.1]) and the risk of MSA decreased with increasing alcohol consumption (P = 0.04). Controls ate fish and sea food more often and drank more tea than cases. Aspirin intake was more frequent among controls than did cases (OR = 0.5 [0.2-1.0]) and the risk of MSA decreased with the frequency of intake (P = 0.0002). MSA was not associated to exposure to pesticides, solvents, and other toxics neither to occupations, except plant and machine operators and assemblers (OR = 10.0 [2.1-47.5]) where the risk of MSA increased with number of years in this occupation (P = 0.004). This case-control study provided new findings about risk factors of MSA. On another hand, it did not confirm the previously reported association between MSA and exposure to pesticides.</div>
</front>
</TEI>
</INIST>
<ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Risk factors of multiple system atrophy: A case‐control study in French patients</title>
<author><name sortKey="Vidal, Jean Ebastien" sort="Vidal, Jean Ebastien" uniqKey="Vidal J" first="Jean-Sébastien" last="Vidal">Jean-Sébastien Vidal</name>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
</author>
<author><name sortKey="Elbaz, Alexis" sort="Elbaz, Alexis" uniqKey="Elbaz A" first="Alexis" last="Elbaz">Alexis Elbaz</name>
</author>
<author><name sortKey="Derkinderen, Pascal" sort="Derkinderen, Pascal" uniqKey="Derkinderen P" first="Pascal" last="Derkinderen">Pascal Derkinderen</name>
</author>
<author><name sortKey="Tzourio, Christophe" sort="Tzourio, Christophe" uniqKey="Tzourio C" first="Christophe" last="Tzourio">Christophe Tzourio</name>
</author>
<author><name sortKey="Alperovitch, Annick" sort="Alperovitch, Annick" uniqKey="Alperovitch A" first="Annick" last="Alpérovitch">Annick Alpérovitch</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:1B70D7EE8D46D33E3294BD13CA164FE92A56515F</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.21857</idno>
<idno type="url">https://api.istex.fr/document/1B70D7EE8D46D33E3294BD13CA164FE92A56515F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000649</idno>
<idno type="wicri:Area/Istex/Curation">000649</idno>
<idno type="wicri:Area/Istex/Checkpoint">001196</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Vidal J:risk:factors:of</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:18307243</idno>
<idno type="wicri:Area/PubMed/Corpus">002312</idno>
<idno type="wicri:Area/PubMed/Curation">002312</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002095</idno>
<idno type="wicri:Area/Ncbi/Merge">002049</idno>
<idno type="wicri:Area/Ncbi/Curation">002049</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002049</idno>
<idno type="wicri:Area/Main/Merge">003218</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Risk factors of multiple system atrophy: A case‐control study in French patients</title>
<author><name sortKey="Vidal, Jean Ebastien" sort="Vidal, Jean Ebastien" uniqKey="Vidal J" first="Jean-Sébastien" last="Vidal">Jean-Sébastien Vidal</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U708, Neuroepidemiology, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>U708, Université Paris 6, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Department of Neurology, Hôpital Saint‐Antoine, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Vidailhet, Marie" sort="Vidailhet, Marie" uniqKey="Vidailhet M" first="Marie" last="Vidailhet">Marie Vidailhet</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Department of Neurology, Hôpital Saint‐Antoine, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U679, Neurology and Experimental Therapeutics, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Elbaz, Alexis" sort="Elbaz, Alexis" uniqKey="Elbaz A" first="Alexis" last="Elbaz">Alexis Elbaz</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U708, Neuroepidemiology, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>U708, Université Paris 6, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Derkinderen, Pascal" sort="Derkinderen, Pascal" uniqKey="Derkinderen P" first="Pascal" last="Derkinderen">Pascal Derkinderen</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Department of Neurology, Center of Clinical Investigations, Hôpital Laënnec, Nantes</wicri:regionArea>
<placeName><settlement type="city">Nantes</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tzourio, Christophe" sort="Tzourio, Christophe" uniqKey="Tzourio C" first="Christophe" last="Tzourio">Christophe Tzourio</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U708, Neuroepidemiology, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>U708, Université Paris 6, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Alperovitch, Annick" sort="Alperovitch, Annick" uniqKey="Alperovitch A" first="Annick" last="Alpérovitch">Annick Alpérovitch</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>INSERM U708, Neuroepidemiology, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>U708, Université Paris 6, Paris</wicri:regionArea>
<placeName><settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-04-30">2008-04-30</date>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="797">797</biblScope>
<biblScope unit="page" to="803">803</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">1B70D7EE8D46D33E3294BD13CA164FE92A56515F</idno>
<idno type="DOI">10.1002/mds.21857</idno>
<idno type="ArticleID">MDS21857</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Alcohol Drinking (epidemiology)</term>
<term>Case-Control Studies</term>
<term>Disease Progression</term>
<term>Environmental Exposure</term>
<term>Female</term>
<term>Food Habits</term>
<term>France (epidemiology)</term>
<term>Humans</term>
<term>Interviews as Topic</term>
<term>Life Style</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Multiple System Atrophy (epidemiology)</term>
<term>Multiple System Atrophy (etiology)</term>
<term>Multiple System Atrophy (prevention & control)</term>
<term>Patient Selection</term>
<term>Questionnaires</term>
<term>Reference Values</term>
<term>Risk Factors</term>
<term>anti‐inflammatory agents, nonsteroidal</term>
<term>environmental exposure</term>
<term>epidemiology</term>
<term>food habits</term>
<term>multiple system atrophy</term>
<term>occupation</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>France</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Alcohol Drinking</term>
<term>Multiple System Atrophy</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Multiple System Atrophy</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Multiple System Atrophy</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Case-Control Studies</term>
<term>Disease Progression</term>
<term>Environmental Exposure</term>
<term>Female</term>
<term>Food Habits</term>
<term>Humans</term>
<term>Interviews as Topic</term>
<term>Life Style</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Patient Selection</term>
<term>Questionnaires</term>
<term>Reference Values</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Multiple system atrophy (MSA) is a rare sporadic progressive neurodegenerative disorder. MSA risk factors are poorly known. The objectives of this case‐control study were to study environmental risk factors associated with MSA. Cases were recruited through five French referral centers. Controls matched for age, gender, and living area were recruited from healthy relatives of inpatients free of any parkinsonian syndrome of the same centers. Subjects were interviewed about exposure to environmental factors (pesticides, solvents, etc.), occupation and food habits, and use of anti‐inflammatory drugs. Odds ratios and 95% confident intervals (OR [95% CI]) were computed using conditional logistic regression. Seventy‐one cases and 71 matched controls were included. Low education level was more frequent in cases than in controls. Controls drank more alcohol than did cases (OR = 0.5 [0.2–1.1]) and the risk of MSA decreased with increasing alcohol consumption (P = 0.04). Controls ate fish and sea food more often and drank more tea than cases. Aspirin intake was more frequent among controls than did cases (OR = 0.5 [0.2–1.0]) and the risk of MSA decreased with the frequency of intake (P = 0.0002). MSA was not associated to exposure to pesticides, solvents, and other toxics neither to occupations, except plant and machine operators and assemblers (OR = 10.0 [2.1–47.5]) where the risk of MSA increased with number of years in this occupation (P = 0.004). This case‐control study provided new findings about risk factors of MSA. On another hand, it did not confirm the previously reported association between MSA and exposure to pesticides. © 2008 Movement Disorder Society</div>
</front>
</TEI>
</ISTEX>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002640 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 002640 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:1B70D7EE8D46D33E3294BD13CA164FE92A56515F |texte= Risk factors of multiple system atrophy: A case‐control study in French patients }}
This area was generated with Dilib version V0.6.23. |